349 related articles for article (PubMed ID: 15084245)
1. Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro.
Brown KA; Aakre ME; Gorska AE; Price JO; Eltom SE; Pietenpol JA; Moses HL
Breast Cancer Res; 2004; 6(3):R215-31. PubMed ID: 15084245
[TBL] [Abstract][Full Text] [Related]
2. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways.
Davies M; Robinson M; Smith E; Huntley S; Prime S; Paterson I
J Cell Biochem; 2005 Aug; 95(5):918-31. PubMed ID: 15861394
[TBL] [Abstract][Full Text] [Related]
3. BMP-7 fails to attenuate TGF-beta1-induced epithelial-to-mesenchymal transition in human proximal tubule epithelial cells.
Dudas PL; Argentieri RL; Farrell FX
Nephrol Dial Transplant; 2009 May; 24(5):1406-16. PubMed ID: 19056781
[TBL] [Abstract][Full Text] [Related]
4. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
5. Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase.
Wang D; Shen Q; Chen YQ; Wang MH
Oncogene; 2004 Mar; 23(9):1668-80. PubMed ID: 15001985
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro evidence for transforming growth factor-beta1-mediated epithelial to mesenchymal transition in esophageal adenocarcinoma.
Rees JR; Onwuegbusi BA; Save VE; Alderson D; Fitzgerald RC
Cancer Res; 2006 Oct; 66(19):9583-90. PubMed ID: 17018615
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells.
Yang T; Chen M; Sun T
Cell Physiol Biochem; 2013; 31(6):863-74. PubMed ID: 23817018
[TBL] [Abstract][Full Text] [Related]
8. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells.
Rhyu DY; Yang Y; Ha H; Lee GT; Song JS; Uh ST; Lee HB
J Am Soc Nephrol; 2005 Mar; 16(3):667-75. PubMed ID: 15677311
[TBL] [Abstract][Full Text] [Related]
9. Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro.
Xie L; Law BK; Chytil AM; Brown KA; Aakre ME; Moses HL
Neoplasia; 2004; 6(5):603-10. PubMed ID: 15548370
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
Kasai H; Allen JT; Mason RM; Kamimura T; Zhang Z
Respir Res; 2005 Jun; 6(1):56. PubMed ID: 15946381
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
12. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
Zeisberg M; Hanai J; Sugimoto H; Mammoto T; Charytan D; Strutz F; Kalluri R
Nat Med; 2003 Jul; 9(7):964-8. PubMed ID: 12808448
[TBL] [Abstract][Full Text] [Related]
13. Kaempferol Suppresses Transforming Growth Factor-β1-Induced Epithelial-to-Mesenchymal Transition and Migration of A549 Lung Cancer Cells by Inhibiting Akt1-Mediated Phosphorylation of Smad3 at Threonine-179.
Jo E; Park SJ; Choi YS; Jeon WK; Kim BC
Neoplasia; 2015 Jul; 17(7):525-37. PubMed ID: 26297431
[TBL] [Abstract][Full Text] [Related]
14. N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition.
Felton VM; Borok Z; Willis BC
Am J Physiol Lung Cell Mol Physiol; 2009 Nov; 297(5):L805-12. PubMed ID: 19648289
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil Inhibits the Growth and Epithelial-to-mesenchymal Transition of Cervical Cancer via the TGF-β1/Smad2/3 Pathway.
Liu P; Pei JJ; Li L; Li JW; Ke XP
Curr Cancer Drug Targets; 2023; 23(2):145-158. PubMed ID: 35975844
[TBL] [Abstract][Full Text] [Related]
16. Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma.
Jiang X; Zhang Z; Song C; Deng H; Yang R; Zhou L; Sun Y; Zhang Q
Chem Biol Interact; 2019 Jul; 307():158-166. PubMed ID: 31059706
[TBL] [Abstract][Full Text] [Related]
17. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition.
Zavadil J; Cermak L; Soto-Nieves N; Böttinger EP
EMBO J; 2004 Mar; 23(5):1155-65. PubMed ID: 14976548
[TBL] [Abstract][Full Text] [Related]
18. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
19. SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system.
Schiemann BJ; Neil JR; Schiemann WP
Mol Biol Cell; 2003 Oct; 14(10):3977-88. PubMed ID: 14517312
[TBL] [Abstract][Full Text] [Related]
20. Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.
Han G; Lu SL; Li AG; He W; Corless CL; Kulesz-Martin M; Wang XJ
J Clin Invest; 2005 Jul; 115(7):1714-23. PubMed ID: 15937546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]